Grail (GRAL) Competitors $38.02 -1.31 (-3.32%) As of 02:30 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GRAL vs. RDNT, BTSG, SHC, PRVA, SGRY, CON, VCYT, LFST, ARDT, and ADUSShould you be buying Grail stock or one of its competitors? The main competitors of Grail include RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Privia Health Group (PRVA), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Veracyte (VCYT), LifeStance Health Group (LFST), Ardent Health Partners (ARDT), and Addus HomeCare (ADUS). These companies are all part of the "healthcare" industry. Grail vs. RadNet BrightSpring Health Services Sotera Health Privia Health Group Surgery Partners Concentra Group Holdings Parent Veracyte LifeStance Health Group Ardent Health Partners Addus HomeCare RadNet (NASDAQ:RDNT) and Grail (NASDAQ:GRAL) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, community ranking, analyst recommendations, valuation, profitability, media sentiment, risk, dividends and earnings. Is RDNT or GRAL more profitable? Grail has a net margin of 0.00% compared to RadNet's net margin of -0.25%. RadNet's return on equity of 4.29% beat Grail's return on equity.Company Net Margins Return on Equity Return on Assets RadNet-0.25% 4.29% 1.45% Grail N/A N/A N/A Do institutionals and insiders hold more shares of RDNT or GRAL? 77.9% of RadNet shares are owned by institutional investors. 5.1% of RadNet shares are owned by insiders. Comparatively, 1.9% of Grail shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Do analysts recommend RDNT or GRAL? RadNet presently has a consensus target price of $69.75, suggesting a potential upside of 15.94%. Grail has a consensus target price of $31.50, suggesting a potential downside of 19.89%. Given RadNet's stronger consensus rating and higher possible upside, equities research analysts clearly believe RadNet is more favorable than Grail.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RadNet 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.40Grail 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25 Does the media refer more to RDNT or GRAL? In the previous week, Grail had 9 more articles in the media than RadNet. MarketBeat recorded 19 mentions for Grail and 10 mentions for RadNet. Grail's average media sentiment score of 1.29 beat RadNet's score of 0.79 indicating that Grail is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Grail 12 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings and valuation, RDNT or GRAL? RadNet has higher revenue and earnings than Grail. RadNet is trading at a lower price-to-earnings ratio than Grail, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRadNet$1.87B2.41$3.04M-$0.43-139.91Grail$130.71M10.82-$2.19B-$60.99-0.64 Does the MarketBeat Community prefer RDNT or GRAL? RadNet received 354 more outperform votes than Grail when rated by MarketBeat users. Likewise, 66.17% of users gave RadNet an outperform vote while only 33.33% of users gave Grail an outperform vote. CompanyUnderperformOutperformRadNetOutperform Votes35666.17% Underperform Votes18233.83% GrailOutperform Votes233.33% Underperform Votes466.67% SummaryRadNet beats Grail on 13 of the 18 factors compared between the two stocks. Get Grail News Delivered to You Automatically Sign up to receive the latest news and ratings for GRAL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GRAL vs. The Competition Export to ExcelMetricGrailMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.41B$3.00B$5.42B$8.48BDividend YieldN/A31.24%5.22%4.11%P/E Ratio-0.6413.2326.8020.05Price / Sales10.82164.59393.93116.47Price / CashN/A57.5638.2534.62Price / BookN/A4.316.864.61Net Income-$2.19B-$22.21M$3.22B$248.19M7 Day Performance19.55%3.62%6.81%2.97%1 Month Performance48.83%7.44%13.72%16.58%1 Year PerformanceN/A4.26%18.24%8.16% Grail Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRALGrail0.79 of 5 stars$38.02-3.3%$31.50-17.1%N/A$1.37B$130.71M-0.621,360Positive NewsGap DownRDNTRadNet3.4035 of 5 stars$57.03+2.3%$69.75+22.3%+2.9%$4.28B$1.83B-814.608,970BTSGBrightSpring Health Services1.6561 of 5 stars$22.35-2.1%$22.89+2.4%+108.0%$3.89B$11.86B-85.9635,000Positive NewsGap UpHigh Trading VolumeSHCSotera Health2.1906 of 5 stars$13.50+2.8%$15.80+17.0%+15.6%$3.83B$1.11B54.003,000Gap UpPRVAPrivia Health Group3.6569 of 5 stars$25.06+0.2%$27.38+9.3%+52.4%$3.04B$1.80B250.63810SGRYSurgery Partners2.8012 of 5 stars$23.26+5.0%$34.75+49.4%-8.9%$2.98B$3.11B-48.4612,200Positive NewsCONConcentra Group Holdings ParentN/A$21.66+1.2%$28.50+31.6%N/A$2.76B$1.90B16.1611,000Gap UpVCYTVeracyte4.0284 of 5 stars$30.76+3.5%$40.90+33.0%+29.2%$2.41B$445.76M-205.07790News CoverageGap UpLFSTLifeStance Health Group2.4112 of 5 stars$5.85+2.1%$8.30+41.9%-22.4%$2.27B$1.28B-22.506,640ARDTArdent Health Partners3.2244 of 5 stars$14.85+2.3%$20.75+39.7%N/A$2.12B$6.02B9.1124,200Analyst ForecastADUSAddus HomeCare4.817 of 5 stars$110.55-0.3%$142.57+29.0%+1.7%$2.03B$1.21B25.3033,200 Related Companies and Tools Related Companies RadNet Alternatives BrightSpring Health Services Alternatives Sotera Health Alternatives Privia Health Group Alternatives Surgery Partners Alternatives Concentra Group Holdings Parent Alternatives Veracyte Alternatives LifeStance Health Group Alternatives Ardent Health Partners Alternatives Addus HomeCare Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GRAL) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Grail, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Grail With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
